Formoterol dry-powder inhalation - Innovata
Alternative Names: Eformoterol Clickhaler; Eformoterol dry-powder inhalation - Innovata Biomed; Eformoterol dry-powder inhalation - ML Laboratories; Formoterol Clickhaler; Formoterol dry-powder inhalation - Innovata BiomedLatest Information Update: 02 Oct 2021
At a glance
- Originator Innovata
- Developer Vectura
- Class Antiasthmatics; Bronchodilators; Ethanolamines; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
Most Recent Events
- 19 Jan 2007 Innovata has been acquired by Vectura
- 30 Sep 2005 Launched for Asthma in Europe (Inhalation)
- 14 Jul 2005 Innovata Biomed has merged with ML Laboratories to form Innovata